Aberdare Partners III LP

Insider CIK 1334248 · CNAT 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	36,634	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	36,634	—	$0	36,634	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	30,216	—	$0	22,203	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2014-02-19	2014-02-25	1,283,589	—	$0	943,355	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise deriv	2013-07-30	2013-08-01	1,727	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	1,727	—	$0	1,727	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	8,552	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	997	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	120	—	$0	120	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	10,483,166	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,701	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	137,626	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	246,775	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,131	—	$0	5,131	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	42,336	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise deriv	2013-07-30	2013-08-01	73,395	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	73,395	—	$0	73,395	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	242,205	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	363,308	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	5,846,236	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise	2013-07-30	2013-08-01	1,727	$0.08	$138	49,712	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	46,594	—	$0	47,985	SEC↗
CNAT Conatus Pharmaceuticals In	X Exercise	2013-07-30	2013-08-01	73,395	$0.08	$5.9K	2,111,930	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	10,614	$11.00	$116.8K	2,121,992	SEC↗
CNAT Conatus Pharmaceuticals In	S Sale	2013-07-30	2013-08-01	552	$11.00	$6.1K	2,111,378	SEC↗
CNAT Conatus Pharmaceuticals In	S Sale	2013-07-30	2013-08-01	14	$11.00	$154	49,698	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	251	$11.00	$2.8K	49,949	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	2,470	$11.00	$27.2K	52,419	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	1,979,321	—	$0	2,038,535	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	104,952	$11.00	$1.15M	2,226,944	SEC↗